Nivolumab for relapsed or refractory Hodgkin lymphoma: Experience in Turkey
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2439_63
Abstract: secondary endpoints. Patients and Methods: Between 8/2011 and 2/2017, 102 pts that received BV were reported. Median age was 32 (range, 16‐73), 56 (55%) were primary refractory. Sixty‐six (65%) received BV after ASCT failure, and… read more here.
Keywords: relapsed refractory; hodgkin lymphoma; refractory hodgkin; pts received ... See more keywords